# Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

> **NCT03801135** · NA · UNKNOWN · sponsor: **University Medical Centre Ljubljana** · enrollment: 20 (estimated)

## Conditions studied

- Humoral Rejection
- Guillain-Barre Syndrome
- Miller Fisher Syndrome
- CIDP
- Good Pasture Syndrome
- Hyperviscosity Syndrome

## Interventions

- **DRUG:** Fibrinogen concentrate
- **OTHER:** Fresh Frozen Plasma

## Key facts

- **NCT ID:** NCT03801135
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-03
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-09-24
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801135, "Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03801135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*